A detailed history of 360 Financial, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, 360 Financial, Inc. holds 4,450 shares of MRK stock, worth $483,225. This represents 0.21% of its overall portfolio holdings.

Number of Shares
4,450
Previous 4,449 0.02%
Holding current value
$483,225
Previous $587,000 6.3%
% of portfolio
0.21%
Previous 0.23%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$123.8 - $132.96 $123 - $132
1 Added 0.02%
4,450 $550,000
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $113 - $131
1 Added 0.02%
4,449 $587,000
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $200 - $218
2 Added 0.04%
4,448 $484,000
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $102 - $114
1 Added 0.02%
4,446 $457,000
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $108 - $118
1 Added 0.02%
4,445 $512,000
Q1 2023

Apr 10, 2023

BUY
$102.94 - $114.86 $308 - $344
3 Added 0.07%
4,444 $472,000
Q2 2022

Aug 04, 2022

BUY
$83.49 - $94.64 $250 - $283
3 Added 0.07%
4,441 $400,000
Q1 2022

Apr 11, 2022

SELL
$73.51 - $82.4 $15,951 - $17,880
-217 Reduced 4.66%
4,438 $371,000
Q4 2021

Jan 18, 2022

BUY
$72.28 - $90.54 $216 - $271
3 Added 0.06%
4,655 $357,000
Q3 2021

Oct 13, 2021

BUY
$71.68 - $78.83 $286 - $315
4 Added 0.09%
4,652 $349,000
Q2 2021

Aug 03, 2021

BUY
$70.31 - $77.77 $210 - $233
3 Added 0.06%
4,648 $362,000
Q1 2021

Apr 28, 2021

SELL
$68.86 - $81.11 $17,008 - $20,034
-247 Reduced 5.05%
4,645 $358,000
Q4 2020

Feb 09, 2021

BUY
$71.77 - $79.65 $215 - $238
3 Added 0.06%
4,892 $400,000
Q2 2020

Jul 15, 2020

BUY
$70.42 - $80.13 $422 - $480
6 Added 0.12%
4,889 $385,000
Q1 2020

Apr 17, 2020

SELL
$63.36 - $87.82 $9,504 - $13,172
-150 Reduced 2.98%
4,883 $376,000
Q4 2019

Feb 28, 2020

BUY
$77.58 - $87.54 $390,460 - $440,588
5,033 New
5,033 $431,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $275B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track 360 Financial, Inc. Portfolio

Follow 360 Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 360 Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on 360 Financial, Inc. with notifications on news.